AMVYTTRA

Serial Number 90182464
606

Registration Progress

Application Filed
Sep 15, 2020
Under Examination
Mar 30, 2021
Approved for Publication
Feb 2, 2021
Published for Opposition
Feb 2, 2021
Registered

Basic Information

Serial Number
90182464
Filing Date
September 15, 2020
Published for Opposition
February 2, 2021
Abandonment Date
October 31, 2022
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 31, 2022
Classes
005

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
300 Third Street
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Sarah Anne Keefe

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

22 events
Date Code Type Description
Oct 31, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Oct 31, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 27, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 27, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 27, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 27, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 22, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 18, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 18, 2022 EXT2 S SOU EXTENSION 2 FILED
Feb 18, 2022 EX2G S SOU EXTENSION 2 GRANTED
Sep 18, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 16, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 16, 2021 EXT1 S SOU EXTENSION 1 FILED
Sep 16, 2021 EX1G S SOU EXTENSION 1 GRANTED
Mar 30, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 2, 2021 PUBO A PUBLISHED FOR OPPOSITION
Feb 2, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 13, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 30, 2020 DOCK D ASSIGNED TO EXAMINER
Dec 30, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 22, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 18, 2020 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of amyloidosis
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005